Treatment target for aggressive leukemia discovered by disrupting its genome organization

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the progression of this aggressive blood cancer. The discovery focuses on disrupting the function of a certain protein complex that cancer cells, including leukemia cells, rely on to maintain their abnormal growth.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup